APA Alıntı

Song, Y., Li, N., Li, Q., Liang, X., Zhang, S., Fan, Q., . . . Huang, J. (2020). HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: A multicenter, single-arm phase II trial. J Immunother Cancer.

Chicago Stili Alıntı

Song, Yan, et al. "HX008, an Anti-PD1 Antibody, Plus Irinotecan As Second-line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer: A Multicenter, Single-arm Phase II Trial." J Immunother Cancer 2020.

MLA Alıntı

Song, Yan, et al. "HX008, an Anti-PD1 Antibody, Plus Irinotecan As Second-line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer: A Multicenter, Single-arm Phase II Trial." J Immunother Cancer 2020.